ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancers (TNBC) are poor-prognosis tumours candidate to chemotherapy as only systemic treatment. We previously found that PRICKLE1, a prometastatic protein involved in planar cell polarity, is upregulated in TNBC. We investigated the protein complex associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Daulat, Avais M., Finetti, Pascal, Revinski, Diego, Silveira Wagner, Mônica, Camoin, Luc, Audebert, Stéphane, Birnbaum, Daniel, Kodjabachian, Laurent, Borg, Jean-Paul, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734648/
https://www.ncbi.nlm.nih.gov/pubmed/30971775
http://dx.doi.org/10.1038/s41416-019-0448-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734648/
https://www.ncbi.nlm.nih.gov/pubmed/30971775
http://dx.doi.org/10.1038/s41416-019-0448-z

Ejemplares similares